DNA Probes-based diagnostics deals with the study to examine the chemical structure of DNA by undoing the presence of abnormal gene sequence of DNA on the DNA strand. This abnormal gene sequence is mainly responsible for causing disease and hence technique such as gene polymorphism can help to limit the chances of occurrence of diseases.
Download exclusive Sample of this report:
Some of the factors driving this market are increase in ageing population, rising consumers awareness, rising investment in pharmaceutical researches and technological advancement. The DNA Probes-based technology is extensively used in diagnostic and also in other fields such as instrumentation development, molecular biology, surface chemistry, microfabrication, biological sample preparation and data handling. The major application area for DNA Probes-based diagnostics market includes Infectious Diseases, genetic predispositions, Molecular HLA (Human Leukocyte Antigen) typing, Forensic, Cancver testing, and others. The infectious diseases segment exhibits the largest application segment for DNA Probes-based diagnostics market. Moreover, genetic predispositions accounts for fastest growing market among others.
The U.S. holds a major share of the global DNA Probes-based diagnostics market as transformational technologies enabling the complex genetic tests to shift from research only laboratories to medical and clinical laboratories. Also, U.S. and Europe together holds the majority of the global DNA Probes-based diagnostics market as about 80% to 90% of DNA tests are performed in the developed regions such as North America and Europe. Nations in Asia Pacific such as China, India are expected to see attractive growth rate due to rise in disposable income.
View exclusive Global strategic Business report :
Some of the market players in this industry are Abbott Laboratories, Becton Dickinson & Company, Siemens Healthcare Diagnostics, Inc., Roche Diagnostics, Genzyme Corporation, Beckman Coulter, Inc., Affymetrix Inc, bioMérieux, QIAGEN, Biogenex Laboratories Inc., Genzyme Corporation, Luminex Molecular Diagnostics, MP Biomedicals, Gen-Probe Incorporated and others.